ASCP Specialist in Hematology (SH) Practice Exam

Heparin's primary mechanism of action in the coagulation cascade is that it enhances the activity of antithrombin III. Antithrombin III is a natural inhibitor of coagulation factors, particularly thrombin and factor Xa. When heparin binds to antithrombin III, it causes a conformational change that increases the affinity of antithrombin for thrombin and factor Xa, thus accelerating the inactivation of these clotting factors. This effect significantly reduces thrombin and factor Xa activity in the coagulation cascade, effectively inhibiting the formation of fibrin clots and preventing thrombus (blood clot) formation.

This interaction is crucial for heparin’s anticoagulant properties and is why it is commonly used in medical settings for the prevention and treatment of thromboembolic disorders. The other options do not accurately capture the comprehensive mechanism of heparin’s action, as it does not act solely on thrombin or factor Xa without involving antithrombin III. Additionally, promoting platelet aggregation is contrary to its anticoagulant effect.